FIELD: medicine, peptides. SUBSTANCE: product: polypeptides of the formula (I): A1-Tгр-Cys-Tyr-A2-Cys--A3-A2--Gly--A3--Cys-Tyr-A2-A2--Cys-A1-NH2, or their salts where: A1 - arginine, arginylarginine; A2 - arginine, lysine; A3 - tyrosine, phenylalanine being cysteine residues can be located at positions 3 and 16 and at positions 4 and 12 can be linked through the disulfide bridge. Pharmaceutical composition has an effective amount of polypeptide (I) as an active component used at dose 10-5000 mg/kg human body mass per a day. Cysteine residues in polypeptide structure at positions 3 and 16 and 7 and 12 were linked through disulfide bridge. Synthesized polypeptides were used in medicine as antibacterial and antiviral (for example, as anti-HIV) agents. EFFECT: improved method of synthesis, enhanced effectiveness of polypeptides. 3 cl, 1 dwg, 4 tbl
Title |
Year |
Author |
Number |
POLYPEPTIDES OR THEIR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTIVIRAL ACTIVITY WITH RESPECT TO HUMAN IMMUNODEFICIENCY VIRUS |
1991 |
- Nobutaka Fudzii[Jp]
- Naoki Jamamoto[Jp]
|
RU2073685C1 |
NEW POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION AGAINST HIV-INFECTION |
1994 |
- Akiesi Matsumoto
- Mitinori Uaki
|
RU2136696C1 |
TRANSIENT METAL SALTS WITH POLYPEPTIDE AND METHOD OF ENHANCEMENT OF POLYPEPTIDE ACTIVITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
1997 |
- Matsumoto Akiesi
- Vaki Mitinori
|
RU2179981C2 |
SUCCINIC ACID DERIVATIVES, SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-GLYCOSAMINOGLYCANE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-POLYAMINOSACCHARIDE DERIVATIVE, AND METHOD OF PREPARING CROSS- LINKED SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE |
1995 |
- Mitinori Vaki
- Kendzi Mijamoto
- Josikhiro Motani
|
RU2169136C2 |
CHONDROITINASE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF |
1993 |
- Nobukazu Khasimoto
- Khideo Motizuki
- Akio Khamai
- Siniti Isikava
- Misako Torikai
- Isao Mijati
|
RU2144833C1 |
SYRINGE FILLED WITH MEDICINAL PREPARATION |
1991 |
|
RU2067874C1 |
DERMATAN SULFATE OR ITS SALT, ANTITHROMBOTIC AGENTS, METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS, METHOD OF PROPHYLAXIS OR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME, METHOD OF MYOCARDIUM INFARCTION TREATMENT |
1994 |
- Akikazu Takada
- Dzjuniti Onaja
- Mikio Arai
- Satosi Mijauti
- Mamoru Kiogasima
- Kejiti Esida
|
RU2153506C2 |
PHOTOCONSOLIDATED DERIVATIVE OF GLYCOSEAMINOGLYCAN, CROSS- -LINKED DERIVATIVE OF GLYCOSEAMINOGLYCAN AND METHODS OF THEIR SYNTHESIS, COMPOSITION FOR MEDICINAL USE, METHOD OF PREVENTION OF CELLULAR AND TISSUE ADHESION |
1993 |
- Takekhisa Matsuda
- Minoo Dzh.Mogkhaddam
- Katsukijo Sakurai
|
RU2139886C1 |
VERSIONS AND ISOFORMS OF ANTIBODIES WITH REDUCED BIOLOGICAL ACTIVITY |
2018 |
- Khosoguti Kensaku
- Kuvayama Maki
- Sejda Tifumi
- Vatanabe Esuke
- Tanaka Nobuyuki
- Sajto Satosi
- Fukuda Masakadzu
|
RU2813990C2 |
SYRINGE TO FILL IN MEDICINAL PREPARATIONS |
1995 |
|
RU2100034C1 |